Know What's Happening in BioTech

Sarepta’s DMD Gene Therapy Staves Off Disease Three Years After Treatment
NewsJan 26, 2026

Sarepta’s DMD Gene Therapy Staves Off Disease Three Years After Treatment

Sarepta Therapeutics reported three‑year data from the Phase III EMBARK trial showing that Elevidys, its gene therapy for Duchenne muscular dystrophy (DMD), continues to stabilize disease progression in ambulatory patients. Motor function measures improved, with a 73% slowdown in time‑to‑rise and...

By BioSpace
HanchorBio and WuXi Biologics Form Fusion Protein Pipeline Partnership
NewsJan 26, 2026

HanchorBio and WuXi Biologics Form Fusion Protein Pipeline Partnership

HanchorBio and WuXi Biologics have signed a strategic collaboration to develop and manufacture multiple next‑generation fusion protein programs from HanchorBio’s Fc‑Based Designer Biologics platform. WuXi will provide end‑to‑end services including cell line creation, process and bioassay development, formulation, and GMP...

By GEN (Genetic Engineering & Biotechnology News)
Hepatotoxicity Headaches: One of the Hardest Risks to De-Risk
BlogJan 26, 2026

Hepatotoxicity Headaches: One of the Hardest Risks to De-Risk

Drug‑induced liver injury (DILI) now accounts for roughly 22 % of safety‑related clinical trial failures and one‑third of post‑approval market withdrawals, making it a critical bottleneck in pharmaceutical development. The blog highlights three recent de‑risking efforts: BMS’s LPA1 antagonist program that...

By Drug Hunter
Soft Robotic Probe Enhances Fetal Monitoring Techniques
NewsJan 26, 2026

Soft Robotic Probe Enhances Fetal Monitoring Techniques

A new soft robotic probe designed for fetal monitoring offers a flexible, skin‑like interface that conforms to the maternal abdomen, delivering continuous, high‑fidelity heart‑rate data. The device incorporates stretchable piezoelectric sensors and wireless telemetry, achieving up to 30% better signal...

By Bioengineer.org
Barnwell Bio Raises $6M in Seed Funding
NewsJan 26, 2026

Barnwell Bio Raises $6M in Seed Funding

Barnwell Bio, a New York‑based precision animal health intelligence firm, announced a $6 million seed round. The financing was led by Twelve Below and included a roster of agritech‑focused investors such as Max Ventures, Dorm Room Fund, and AgVentures Alliance. Barnwell...

By FinSMEs
Genyro Licences DNA Builder From Caltech; Dizal Targets Hong Kong Listing
NewsJan 26, 2026

Genyro Licences DNA Builder From Caltech; Dizal Targets Hong Kong Listing

Genyro, a San Diego biotech startup, has secured exclusive rights to Caltech’s DNA builder technology, a platform that automates the assembly of long DNA sequences. The system combines high‑throughput enzymatic reactions with error‑correction software, enabling gene circuits and even whole...

By Endpoints News
Specially Textured Metasurfaces for Identifying Aggressive Cancer
BlogJan 26, 2026

Specially Textured Metasurfaces for Identifying Aggressive Cancer

Researchers at Hebrew University have created textured metasurfaces that reveal aggressive cancer cells through their physical interactions, not genetic markers. The nano‑patterned surfaces cause aggressive cells to grip more tightly, engulf particles, and alter shape, behaviors missed on flat substrates....

By Nanowerk
Pharmaceutical Technology Is Now PharmTech: A Sharper Name for a Smarter Industry
NewsJan 26, 2026

Pharmaceutical Technology Is Now PharmTech: A Sharper Name for a Smarter Industry

PharmTech, formerly known as Pharmaceutical Technology for nearly five decades, has officially rebranded with a new name, logo, and digital experience. The company highlights a refreshed content strategy slated through 2025 aimed at scientists, innovators, and C‑suite leaders. It emphasizes...

By Pharmaceutical Technology
Fragment Merging – and Flipping – on the Leucine Zipper of MITF
BlogJan 26, 2026

Fragment Merging – and Flipping – on the Leucine Zipper of MITF

Researchers at Novartis used 19F NMR to screen the DNA‑binding domain of the microphthalmia‑associated transcription factor (MITF), a leucine‑zipper protein implicated in melanoma. Only nine fragments emerged from the LEF4000 library, reflecting the target’s difficulty. Two series were merged, yielding...

By Practical Fragments
New Gussevia Species Found on Astronotus Ocellatus Fish
NewsJan 26, 2026

New Gussevia Species Found on Astronotus Ocellatus Fish

Researchers have described a new monogenean parasite species in the genus Gussevia that infects the gills of the ornamental Oscar fish (Astronotus ocellatus). The specimen was collected from the semi‑arid Caatinga region of northeastern Brazil, an area previously under‑sampled for...

By Bioengineer.org
Bausch Health Hit as Xifaxan Successor Flunks Trials
NewsJan 26, 2026

Bausch Health Hit as Xifaxan Successor Flunks Trials

Bausch Health’s SSD rifaximin program, aimed at primary prevention of hepatic encephalopathy, failed both phase‑3 RED‑C trials, missing the primary efficacy endpoint. The setback caused the company’s shares to tumble about 11 % and raises concerns as Xifaxan, its top‑selling drug,...

By pharmaphorum
A Clearer Path to Relief: Sinusitis Treatments on the Way
NewsJan 26, 2026

A Clearer Path to Relief: Sinusitis Treatments on the Way

The FDA is poised to approve Dupixent for allergic fungal rhinosinusitis, marking its ninth indication and expanding treatment options for adults and children over five. Phase‑3 data showed a 50% reduction in nasal congestion and a 60.8% shrinkage of nasal...

By Labiotech.eu
Express Scripts Considering Settlement in FTC Insulin Price Lawsuit
NewsJan 26, 2026

Express Scripts Considering Settlement in FTC Insulin Price Lawsuit

Cigna’s pharmacy‑benefit manager Express Scripts is reportedly close to a settlement with the Federal Trade Commission over allegations that the PBM helped inflate insulin prices. The FTC has paused the broader case to allow settlement talks with Express Scripts, CVS...

By BioPharma Dive
Section 3: Ligand Binding Basics
BlogJan 26, 2026

Section 3: Ligand Binding Basics

The post outlines core principles of ligand‑target binding essential for drug discovery, emphasizing how small molecules engage protein sites. It highlights the interplay of binding kinetics, thermodynamics, and inhibition mechanisms in shaping potency. The author explains how affinity can be...

By Drug Hunter
Unveiling Oogenesis in Alligator: LncRNA-miRNA-mRNA Insights
NewsJan 26, 2026

Unveiling Oogenesis in Alligator: LncRNA-miRNA-mRNA Insights

Researchers have mapped the lncRNA‑miRNA‑mRNA regulatory network governing oogenesis in the American alligator for the first time. The study identified over a hundred differentially expressed long non‑coding RNAs and linked them to key follicular development pathways. Comparative analysis shows significant...

By Bioengineer.org
Midlife Activity Linked to Men’s Hip Fracture Risk
NewsJan 26, 2026

Midlife Activity Linked to Men’s Hip Fracture Risk

A new longitudinal study in the Archives of Osteoporosis links midlife physical activity and body‑mass index (BMI) to hip‑fracture risk in men five decades later. Researchers analyzed thousands of participants from the NOREPOS cohort, finding that higher activity levels during...

By Bioengineer.org
Merck Backs Off Revolution After Failing To Agree on Price: WSJ
NewsJan 26, 2026

Merck Backs Off Revolution After Failing To Agree on Price: WSJ

Merck and Revolution Medicines ended acquisition talks after failing to agree on a purchase price, with proposals hovering between $28 billion and $32 billion. The biotech’s lead drug, daraxonrasib, has generated strong early‑stage data and earned an FDA priority voucher, making it...

By BioSpace
UK Medicines Agency Seized 20M Illegal Drugs Last Year, Including GLP-1s
NewsJan 26, 2026

UK Medicines Agency Seized 20M Illegal Drugs Last Year, Including GLP-1s

Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) reported seizing nearly 20 million doses of illegally traded medicines in 2025, valued at roughly £200 million. The haul included a large share of GLP‑1 agonists, which have surged in demand for obesity and...

By Endpoints News
COPD Patients Will Get Access to Dupixent via NHS
NewsJan 26, 2026

COPD Patients Will Get Access to Dupixent via NHS

The UK’s health technology assessment agency NICE has recommended Sanofi‑Regeneron’s Dupixent for adults with eosinophilic, uncontrolled COPD, making it the first targeted biologic for the disease. Approved in September 2024, the IL‑4/IL‑13 inhibitor is prescribed alongside standard LABA/LAMA ±ICS therapy...

By pharmaphorum
FeNNix-Bio1 Delivers Quantum‑Accurate MD, Open for Academia
SocialJan 26, 2026

FeNNix-Bio1 Delivers Quantum‑Accurate MD, Open for Academia

#compchem #compbio 🚀 𝐅𝐞𝐍𝐍𝐢𝐱-𝐁𝐢𝐨1 enables to perform extremely fast molecular dynamics simulations at hashtag#quantum accuracy under various #GPU-accelerated frameworks. 🚀 As some people asked me, the 𝐅𝐞𝐍𝐍𝐢𝐱-𝐁𝐢𝐨1 #machinelearning foundation model is fully available for academic groups (ASL licence) at various places: - 👉...

By Jean-Philip Piquemal
Genmab Halts Enrollment for Cancer Drug From ProfoundBio Buyout
NewsJan 26, 2026

Genmab Halts Enrollment for Cancer Drug From ProfoundBio Buyout

Genmab announced it has stopped enrolling patients in an early‑stage trial of a cancer candidate acquired from ProfoundBio. The drug was part of Genmab’s $1.8 billion purchase of the US‑China biotech firm. The pause comes shortly after the acquisition closed, raising...

By Endpoints News
Nuclear Export of HMGB1 Drives Astrocyte Senescence
BlogJan 26, 2026

Nuclear Export of HMGB1 Drives Astrocyte Senescence

The study shows that high‑mobility group box‑1 (HMGB1) expression declines in astrocytes as they age, and astrocyte‑specific HMGB1 knockout accelerates mouse aging. Nuclear HMGB1 acts as an anti‑senescence factor, while extracellular HMGB1 functions as a pro‑senescent, inflammatory signal. By inhibiting...

By Fight Aging!
Hemoglobin in the Progression of Aging
BlogJan 26, 2026

Hemoglobin in the Progression of Aging

Hemoglobin, traditionally viewed as the body’s oxygen carrier, also modulates inflammation, oxidative stress, and vascular health, all of which influence aging trajectories. In older adults, anemia is linked to frailty, cognitive impairment, higher hospitalization rates, and mortality, while elevated hemoglobin...

By Fight Aging!
Tracking Corvid Vocalizations with Miniature Tech
NewsJan 26, 2026

Tracking Corvid Vocalizations with Miniature Tech

Researchers published a study in *Animal Cognition* demonstrating that ultra‑light, low‑impact tags can record high‑resolution vocalizations from free‑living corvids. The tags captured real‑time calls and associated body language, revealing distinct vocal patterns for kin versus strangers. Findings highlight corvids' sophisticated...

By Bioengineer.org
Analyzing Risk Factors in Hip Dysplasia via Ultrasound
NewsJan 26, 2026

Analyzing Risk Factors in Hip Dysplasia via Ultrasound

A recent clinical study leveraged neonatal ultrasound to pinpoint risk factors for developmental hip dysplasia (DDH). Researchers correlated specific sonographic markers with maternal BMI, genetic predisposition, and biomechanical variables. The analysis demonstrated that early, standardized imaging can markedly lower the...

By Bioengineer.org
Introducing the Sunday Times Tech 100: Life Sciences Part 1
NewsJan 26, 2026

Introducing the Sunday Times Tech 100: Life Sciences Part 1

The Sunday Times Tech 100 list shows that 23 of the 100 fastest‑growing UK private tech firms operate in life sciences, underscoring the sector’s momentum. The list aggregates £3.7 billion in revenue and 23,100 jobs, with a focus this week on five...

By pharmaphorum
Early Mortality Risks in Chinese Acute Leukemia Kids
NewsJan 26, 2026

Early Mortality Risks in Chinese Acute Leukemia Kids

A recent multicenter study of 1,842 Chinese children with acute leukemia identified several factors that double early‑mortality risk within 30 days of diagnosis. High‑risk features included age under one year, severe hyperleukocytosis, and delayed initiation of induction chemotherapy beyond 48...

By Bioengineer.org
Gender Differences in Anxiety and Depression in Mice
NewsJan 26, 2026

Gender Differences in Anxiety and Depression in Mice

A recent pre‑clinical study reveals pronounced gender differences in anxiety and depression phenotypes among laboratory mice. Female mice displayed significantly higher anxiety‑like behavior and depressive‑like immobility, while male mice showed milder responses under identical stress protocols. Hormonal profiling linked elevated...

By Bioengineer.org
From Detection to Prevention: How Sponsored Testing Can Transform Patient Outcomes
NewsJan 26, 2026

From Detection to Prevention: How Sponsored Testing Can Transform Patient Outcomes

Diagnostic testing is evolving from a purely detection tool to a preventive strategy, especially in Canada where provincial coverage varies. Pharmaceutical sponsors are launching paid testing programs that eliminate cost barriers, granting patients access to advanced risk‑identification assays for conditions...

By BioPharma Dive
The Crucial Role of Raw Material Selection for Success in Cell Therapy Manufacturing
NewsJan 26, 2026

The Crucial Role of Raw Material Selection for Success in Cell Therapy Manufacturing

Cell therapy’s promise hinges on manufacturing consistency, which is driven by the quality of raw (ancillary) materials such as media, cytokines, scaffolds, and disposables. Variability in these inputs can cause fluctuations in cell potency, safety, and regulatory compliance, especially when...

By BioPharma Dive
Granzyme B-Mimic Nanozyme Targets Cancer Cells
NewsJan 26, 2026

Granzyme B-Mimic Nanozyme Targets Cancer Cells

Researchers have engineered a granzyme B‑mimic nanozyme that selectively attacks cancer cells by replicating the proteolytic activity of the immune‑system enzyme granzyme B. Laboratory tests show the nanozyme cleaves tumor‑specific membrane proteins, triggering apoptosis while sparing healthy tissue. In mouse...

By Bioengineer.org
Two-Faced Nanoparticles Revive Antibiotics Against Superbugs
BlogJan 26, 2026

Two-Faced Nanoparticles Revive Antibiotics Against Superbugs

Researchers at the University of Osaka have engineered amphiphilic Janus nanoparticles that physically breach the outer membrane of drug‑resistant Gram‑negative bacteria. By creating pores, these two‑faced particles enable conventional antibiotics to enter cells and kill pathogens such as Escherichia coli...

By Nanowerk
Streamlining ACMG Variant Classifications with BIAS-2015
NewsJan 26, 2026

Streamlining ACMG Variant Classifications with BIAS-2015

The study by Eisenhart, Brickey and Nadon introduces BIAS‑2015 v2.1.1, a machine‑learning algorithm designed to automate ACMG variant classifications. Benchmarking against the FDA‑approved eRepo dataset shows the tool achieves accuracy comparable to the gold‑standard reference. By learning from previously classified variants,...

By Bioengineer.org
Long-Term Crop Diversity Boosts Profit, Biodiversity, Ecosystems
NewsJan 26, 2026

Long-Term Crop Diversity Boosts Profit, Biodiversity, Ecosystems

A recent study finds that farms practicing long‑term crop diversity see higher profit margins, increased biodiversity, and stronger ecosystem services. Over a decade, diversified rotations reduced input costs by up to 15% while boosting yields of staple crops. Soil health...

By Bioengineer.org
Exploring Incentives for Buprenorphine Treatment in Family Medicine
NewsJan 26, 2026

Exploring Incentives for Buprenorphine Treatment in Family Medicine

The article examines emerging financial and regulatory incentives aimed at expanding buprenorphine prescribing within family medicine practices. It highlights federal grant programs, revised reimbursement structures, and streamlined waiver processes that lower barriers for primary‑care clinicians. The piece also discusses how...

By Bioengineer.org
Stress Effects on Learning and Memory in Cichlids
NewsJan 26, 2026

Stress Effects on Learning and Memory in Cichlids

Recent laboratory studies reveal that acute and chronic stress markedly diminish learning speed and memory retention in several cichlid species. Researchers measured cortisol spikes and employed maze navigation and color‑association tasks, finding up to a 40% performance drop under stress....

By Bioengineer.org
LncRNA PVT1 Influences Endothelial Function in DVT
NewsJan 26, 2026

LncRNA PVT1 Influences Endothelial Function in DVT

Researchers have identified the long non‑coding RNA PVT1 as a key regulator of endothelial function in deep vein thrombosis (DVT). In patient‑derived vein samples, PVT1 expression is markedly elevated, correlating with reduced nitric oxide bioavailability and heightened inflammatory signaling. In...

By Bioengineer.org
Environmental Exposome’s Role in Heart Failure Risk
NewsJan 26, 2026

Environmental Exposome’s Role in Heart Failure Risk

A new nationwide study finds that cumulative environmental exposures—collectively known as the exposome—significantly raise the risk of heart failure. By integrating air‑pollution data, chemical toxin records, and lifestyle factors with electronic health records of over 1.2 million patients, researchers quantified a...

By Bioengineer.org
Peptide Protects Dopaminergic Neurons in Parkinson’s Model
NewsJan 26, 2026

Peptide Protects Dopaminergic Neurons in Parkinson’s Model

Researchers led by Choe have demonstrated that a nine‑amino‑acid peptide derived from the plant protein osmotin can protect dopaminergic neurons in a mouse model of Parkinson's disease. The peptide attenuated α‑synuclein‑ and MPTP‑induced glial activation, reducing neuroinflammatory cytokine levels. Histological...

By Bioengineer.org
To Accelerate Rare Disease Progress, Take a Sandbox Approach
NewsJan 26, 2026

To Accelerate Rare Disease Progress, Take a Sandbox Approach

A sandbox framework is proposed to overhaul rare‑disease drug development, allowing regulators, sponsors, patients and academics to collaborate in real time. The model groups therapies into small‑molecule, biologic and complex sandboxes, enabling a continuous IND that spans Phase 1‑3 and eliminates...

By BioSpace
Energy Devices for Acne in Skin of Color
NewsJan 26, 2026

Energy Devices for Acne in Skin of Color

Energy‑based devices such as lasers, intense pulsed light (IPL) and radio‑frequency are increasingly used to treat acne in patients with darker skin tones. Recent clinical trials show that long‑pulse Nd:YAG lasers and low‑fluence fractional lasers reduce inflammatory lesions while minimizing...

By Bioengineer.org
3D Printed Polymers Mimic Atherosclerotic Blood Vessels’ Properties
NewsJan 26, 2026

3D Printed Polymers Mimic Atherosclerotic Blood Vessels’ Properties

Researchers have created 3D‑printed polymers that accurately mimic the mechanical behavior of atherosclerotic blood vessels, addressing a long‑standing gap in surgical training models. By integrating UV‑induced and hydrolysis‑induced degradation, the materials can evolve from healthy‑like compliance to plaque‑like brittleness, offering...

By Bioengineer.org
Deal Flow Quality Trumps Picking Skill for VC Success
SocialJan 26, 2026

Deal Flow Quality Trumps Picking Skill for VC Success

Deal Flow Quality beats “picking skill” The figure below is a reminder that most VC chest-thumping is aimed at the wrong variable. In venture, outcomes are driven by two levers: >Pool quality (base rate): how many real winners exist in what you see >Picking...

By BowTiedBiotech
Ethiopia Declares First Marburg Outbreak over After 42 Days
SocialJan 26, 2026

Ethiopia Declares First Marburg Outbreak over After 42 Days

This is good news indeed. Ethiopia has declared its first recorded #Marburg outbreak is over, after going 42 days without new cases. There were 14 confirmed cases & 9 deaths.

By Helen Branswell
Zonal Endothelial Cell Diversity Drives Renal Vascular Growth
NewsJan 26, 2026

Zonal Endothelial Cell Diversity Drives Renal Vascular Growth

Researchers have uncovered that endothelial cells in the kidney exhibit distinct zonal identities, each contributing uniquely to renal vascular growth. Using single‑cell RNA sequencing, the team mapped spatially resolved endothelial subpopulations and identified zone‑specific signaling pathways that promote angiogenesis. Functional...

By Bioengineer.org
Future Oranges May Come with Built‑in Biodegradable Packaging
SocialJan 26, 2026

Future Oranges May Come with Built‑in Biodegradable Packaging

One day in the future our plant scientists will engineer oranges to have their own biodegradable packaging. Until then… https://t.co/IpqaTyuiJN

By Tom Ellis
Exploring CDPK Genes in Liriodendron Chinense Under Stress
NewsJan 25, 2026

Exploring CDPK Genes in Liriodendron Chinense Under Stress

Researchers have catalogued the calcium‑dependent protein kinase (CDPK) gene family in Liriodendron chinense, a prized ornamental and timber species. Twelve CDPK genes were identified, and transcriptomic profiling showed distinct up‑regulation under drought, salinity, and cold stress. Promoter analyses uncovered multiple...

By Bioengineer.org
Opioid Treatment’s Effects on Jail Mental Health Services
NewsJan 25, 2026

Opioid Treatment’s Effects on Jail Mental Health Services

A growing number of correctional facilities are integrating opioid agonist treatment (OAT) into their mental health services, aiming to curb overdose deaths and improve psychiatric outcomes among inmates. Recent pilot programs report a 30% drop in emergency psychiatric visits and...

By Bioengineer.org
Support for FDA Action on Menopausal Hormone Therapy
NewsJan 25, 2026

Support for FDA Action on Menopausal Hormone Therapy

The U.S. Food and Drug Administration announced a new regulatory push targeting menopausal hormone therapy (MHT), proposing stricter labeling requirements and heightened post‑market surveillance. The agency highlighted recent safety data linking certain formulations to increased cardiovascular and breast cancer risks,...

By Bioengineer.org